# FDA Inspection 1082112 - Division of Nuclear Medicine PET Radiopharmaceutical Production Program - March 07, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/division-of-nuclear-medicine-pet-radiopharmaceutical-production-program/cd5ad25d-b355-4a63-b91c-bc8cd1c3af10
Source feed: FDA_Inspections

> FDA Inspection 1082112 for Division of Nuclear Medicine PET Radiopharmaceutical Production Program on March 07, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082112
- Company Name: Division of Nuclear Medicine PET Radiopharmaceutical Production Program
- Inspection Date: 2019-03-07
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1282498 - 2025-09-17](https://www.globalkeysolutions.net/records/fda_inspections/division-of-nuclear-medicine-pet-radiopharmaceutical-production-program/d07b4dd0-b518-41e7-83f7-57242640934c)
- [FDA Inspection 866735 - 2014-02-21](https://www.globalkeysolutions.net/records/fda_inspections/division-of-nuclear-medicine-pet-radiopharmaceutical-production-program/edba39ad-e495-4534-b2e8-2798bfd3f475)

Company: https://www.globalkeysolutions.net/companies/division-of-nuclear-medicine-pet-radiopharmaceutical-production-program/262f6bbf-8bbc-4786-936b-f5dc1e452b48

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c